Immuron (IMRN) Other Non-Current Assets (2018 - 2023)
Immuron's quarterly Other Non-Current Assets came in at $7846.9 in Q4 2023, down 48.19% year-on-year from $15146.1 in Q4 2022, and down 99.35% quarter-over-quarter from $1.2 million in Q3 2023.
Immuron has reported Other Non-Current Assets for 5 years, with the latest figure at $7846.9 in Q4 2023.
- For the quarter ending Q4 2023, Other Non-Current Assets fell 48.19% year-over-year to $7846.9; the trailing twelve-month figure through Dec 2023 stood at $7846.9 (down 48.19% YoY), and the FY2023 full-year result was $18340.3, up 21.09% from the prior year.
- Other Non-Current Assets for Q4 2023 stood at $7846.9, down from $1.2 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $17.8 million in Q2 2022, with the low at $7846.9 in Q4 2023.
- Average Other Non-Current Assets over 4 years is $2.7 million, with a median of $573601.7 recorded in 2023.
- Year-over-year, Other Non-Current Assets slipped 13.45% in 2020 and tumbled 99.93% in 2023.
- Tracing IMRN's Other Non-Current Assets over 4 years: stood at $1.3 million in 2019, then retreated by 13.45% to $1.1 million in 2020, then sank by 98.66% to $15146.1 in 2022, then slumped by 48.19% to $7846.9 in 2023.
- The last three Other Non-Current Assets figures came in at $7846.9 (Q4 2023), $1.2 million (Q3 2023), and $18340.3 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Immuron | 1.27 Bn | 1.27 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 7,846.88 |
| Sep 28, 2023 | 1.20 Mn |
| Aug 30, 2023 | 18,340.34 |
| Jun 30, 2023 | 12,257.96 |
| Dec 31, 2022 | 15,146.13 |
| Jun 30, 2022 | 17.81 Mn |
| Jun 30, 2020 | 1.13 Mn |
| Jun 30, 2019 | 1.30 Mn |
| Jun 30, 2018 | 1.64 Mn |